Performance Comparison of Microfluidic and Immunomagnetic Platforms for Pancreatic CTC Enrichment
November 15, 2025
Brand Name :
Ibustrin
Synonyms :
indobufen
Class :
Antiplatelet Agent, Anticoagulants
Dosage Forms & StrengthsÂ
TabletÂ
200 mgÂ
Take a dose of 200 to 400 mg orally daily in two divided doses
Not determinedÂ
Refer to adult dosingÂ
indobufen: it may decrease the antihypertensive activities of acebutolol
indobufen: it may decrease the excretion rate of carbidopa
abrocitinib: it may increase the risk of bleeding and thrombocytopenia with indobufen
aceclofenac: it may increase the risk of adverse effects of indobufen
acemetacin: it may increase the risk of adverse effects with indobufen
acetaminophen: it may increase the risk or severity of adverse effects with indobufen
bethanechol: it may decrease the therapeutic efficacy of indobufen
betrixaban: it may increase the risk of bleeding can be increased with indobufen
bexarotene: it may increase the risk of bleeding with indobufen
bimatoprost: it may decrease the therapeutic efficacy of indobufen
carboplatin: it may increase the risk of nephrotoxicity with indobufen
cariprazine: it may increase the risk of hypertension with indobufen
Actions and SpectrumÂ
indobufen is used to prevent the formation of blood clots by inhibiting platelet aggregation. Platelets are blood cells that play a crucial role in blood clot formation. When platelets aggregate, they can form clots in blood vessels, which can lead to various cardiovascular problems, including heart attacks and strokes.
Frequency not defined Â
Haemostatic disorders Â
Diarrhea Â
UlcerÂ
Bleeding
Black Box WarningÂ
NoneÂ
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
<b>Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
indobufen achieves this by interfering with the function of platelet receptors. Inhibition of this receptor reduces platelet adhesion and aggregation, preventing the formation of pathological blood clots.Â
PharmacodynamicsÂ
indobufen possesses anti-inflammatory properties. Its pharmacodynamic action involves inhibiting the activity of enzymes known as cyclooxygenases (COX). Â
These enzymes are responsible for the production of prostaglandins, which are inflammatory mediators.Â
PharmacokineticsÂ
Absorption  Â
indobufen is absorbed from the gastrointestinal tract after oral administration. Â
DistributionÂ
indobufen is distributed throughout the body.Â
MetabolismÂ
indobufen undergoes hepatic metabolism. Â
Elimination and excretionÂ
indobufen is excreted through the urine.Â
AdministrationÂ
indobufen is administered orally and available in tablet form.
Patient information leafletÂ
Generic Name: indobufenÂ
Why do we use indobufen?Â
indobufen is used in the prevention of platelet aggregation which leads to thrombus formation. Â
indobufen is used to prevent coronary and peripheral artery occlusion.